Global Lab Automation Market Set To Grow To $6.3bn By 2022

02 August 2018
Pharma

Visiongain’ has launched a new pharma report Global Lab Automation Market Forecast 2018-2028: Modular Automation, Total Lab Automation, Automated Liquid Handling, Microplate Readers, Software & Informatics, Automated Storage & Retrieval Systems, Automated Integrated Workstations, Reagent Dispensers, Microplate Washers, Multi-mode, Single-mode, Laboratory Information Management System, Electronic Laboratory Notebook, Scientific Data Management Systems, Drug Discovery, Clinical Diagnostics, Genomic Solutions, Proteomic Solutions, Others

Laboratory automation system includes automated lab instruments, software and devices which offer benefits such as reduction of cycle time, increasing productivity, improvement of workflow coverage and improvement of data quality. The laboratory automation or robotic products are offered in modified form, according to the necessity of specific laboratories or researcher. Therefore, lab automation becomes essential in laboratories for handling high volumes of sample at faster rate. This system offers smooth solution to lab procedures such as decapping, centrifugation, aliquoting, recapping and sorting among others.

The lead analyst of the report commented “In 2017, the automated liquid handling submarket held the largest market share in the global lab automation market. Growth in this market is set to be driven by the precision and accuracy offered, reduced cost of labour and the availability of a wide range of application.

The microplate readers submarket is expected to grow at the highest CAGR in the forecast period from 2018 to 2028. The growth of this submarket is driven by ease of use, as well as combination of multiple measurement technologies such as absorbance, fluorescence, and luminescence into one compact instrument.”

Leading companies featured in the report include Danaher Corporation, Thermo Fisher Scientific, Inc., Roche Holding AG, Siemens Healthineers, Qiagen N.V., PerkinElmer, Inc., Agilent Technologies, Abbott Laboratories, Tecan Trading AG, Labcyte, Inc.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

Read

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

Read

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

Read

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever